1076 related articles for article (PubMed ID: 11560041)
1. [Systemic sclerosis (scleroderma) without scleroderma].
Nadashkevych ON
Lik Sprava; 2001; (3):93-4. PubMed ID: 11560041
[TBL] [Abstract][Full Text] [Related]
2. [Morphological changes in the skin in scleroderma in the process of treatment with unithiol].
Dubinskiĭ AA; Tseraidis GS; Guĭda PP; Petrusenko EA; Babykina EA
Vrach Delo; 1978 Oct; (10):112-4. PubMed ID: 716343
[No Abstract] [Full Text] [Related]
3. [How I explore ... the skin functional involvement in scleroderma].
Hermanns-Lê T; Piérard-Franchimont C; Piérard GE; André B; De Roover C; Renwart L; Delvenne P
Rev Med Liege; 2013 Mar; 68(3):141-7. PubMed ID: 23614323
[TBL] [Abstract][Full Text] [Related]
4. Ichthyotic-appearing skin changes associated with childhood morphea, systemic sclerosis, and systemic lupus erythematosus/scleroderma overlap.
Williams CM; Storm CA; Burns C; Rigby W; Dinulos JG
Pediatr Dermatol; 2010; 27(2):170-3. PubMed ID: 20537069
[TBL] [Abstract][Full Text] [Related]
5. Cutaneous and subcutaneous inflammatory sclerosis syndromes.
Doyle JA; Connolly SM; Winkelmann RK
Arch Dermatol; 1982 Nov; 118(11):886-90. PubMed ID: 7138043
[TBL] [Abstract][Full Text] [Related]
6. Systemic and localized scleroderma in children: current and future treatment options.
Rosenkranz ME; Agle LM; Efthimiou P; Lehman TJ
Paediatr Drugs; 2006; 8(2):85-97. PubMed ID: 16608370
[TBL] [Abstract][Full Text] [Related]
7. Peristomal morphoea in a patient with systemic sclerosis.
Jiang KW; Zagarella SS; Chan L; Harris A
Australas J Dermatol; 2020 Nov; 61(4):e451-e452. PubMed ID: 32567671
[No Abstract] [Full Text] [Related]
8. [Scleroatrophic lichen and its relation to scleroderma].
Kalamkarian AA; Fedorova EG
Vestn Dermatol Venerol; 1982; (12):4-7. PubMed ID: 7158014
[No Abstract] [Full Text] [Related]
9. Capillary abnormalities, Raynaud's phenomenon, and systemic sclerosis in patients with localized scleroderma.
Maricq HR
Arch Dermatol; 1992 May; 128(5):630-2. PubMed ID: 1575525
[TBL] [Abstract][Full Text] [Related]
10. [Scleroderma in children].
Frati Munari AC; Culebro Nieves G; Velázquez E; Podoswa G
Bol Med Hosp Infant Mex; 1979; 36(2):201-14. PubMed ID: 758191
[TBL] [Abstract][Full Text] [Related]
11. Skin sclerosis as a manifestation of POEMS syndrome.
Hasegawa M; Orito H; Yamamoto K; Matsushita T; Hamaguchi Y; Fujimoto M; Takehara K
J Dermatol; 2012 Nov; 39(11):922-6. PubMed ID: 22724593
[TBL] [Abstract][Full Text] [Related]
12. Presentations and treatment of childhood scleroderma: localized scleroderma, eosinophilic fasciitis, systemic sclerosis, and graft-versus-host disease.
Hedrich CM; Fiebig B; Hahn G; Suttorp M; Gahr M
Clin Pediatr (Phila); 2011 Jul; 50(7):604-14. PubMed ID: 21525084
[TBL] [Abstract][Full Text] [Related]
13. [Madecassol treatment of systemic and localized scleroderma].
Guseva NG; Starovoĭtova MN; Mach ES
Ter Arkh; 1998; 70(5):58-61. PubMed ID: 9644746
[TBL] [Abstract][Full Text] [Related]
14. [Systemic sclerosis--clinical course and treatment possibilities].
Szymańska E; Maj M; Rudnicka L
Przegl Lek; 2005; 62(12):1538-41. PubMed ID: 16786791
[TBL] [Abstract][Full Text] [Related]
15. Successful treatment of scleroderma with PUVA therapy.
Kanekura T; Fukumaru S; Matsushita S; Terasaki K; Mizoguchi S; Kanzaki T
J Dermatol; 1996 Jul; 23(7):455-9. PubMed ID: 8772023
[TBL] [Abstract][Full Text] [Related]
16. [Classification of circumscribed scleroderma. A multicenter study of 286 patients. The Scleroderma Study Group of the Society of Dermatologic Research].
Hautarzt; 1990 Jan; 41(1):16-21. PubMed ID: 2179167
[TBL] [Abstract][Full Text] [Related]
17. Localized and systemic scleroderma show different histological responses to methotrexate therapy.
Seyger MM; van den Hoogen FH; van Vlijmen-Willems IM; van de Kerkhof PC; de Jong EM
J Pathol; 2001 Apr; 193(4):511-6. PubMed ID: 11276011
[TBL] [Abstract][Full Text] [Related]
18. Stimulating circulation to end stasis in scleroderma.
Yuan X; Li JD; Chen WJ; Li ZS; Zhu HT; Liu JW; Zhu MJ
Chin Med J (Engl); 1981 Feb; 94(2):85-93. PubMed ID: 6786844
[No Abstract] [Full Text] [Related]
19. Topical tocoretinate improved hypertrophic scar, skin sclerosis in systemic sclerosis and morphea.
Mizutani H; Yoshida T; Nouchi N; Hamanaka H; Shimizu M
J Dermatol; 1999 Jan; 26(1):11-7. PubMed ID: 10063206
[TBL] [Abstract][Full Text] [Related]
20. Systemic and localized scleroderma.
Chung L; Lin J; Furst DE; Fiorentino D
Clin Dermatol; 2006; 24(5):374-92. PubMed ID: 16966019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
